Canadian Journal of Gastroenterology and Hepatology

Scope & Guideline

Unveiling the Latest in Gastrointestinal and Liver Science

Introduction

Delve into the academic richness of Canadian Journal of Gastroenterology and Hepatology with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2291-2789
PublisherHINDAWI LTD
Support Open AccessYes
CountryEgypt
TypeJournal
Convergefrom 2014 to 2024
AbbreviationCAN J GASTROENTEROL / Can. J. Gastroenterol. Hepatol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON W1T 5HF, ENGLAND

Aims and Scopes

The Canadian Journal of Gastroenterology and Hepatology primarily focuses on advancing knowledge in the fields of gastroenterology and hepatology through original research, reviews, and clinical studies. Its scope encompasses a wide range of topics related to liver diseases, gastrointestinal disorders, and their management.
  1. Liver Diseases and Hepatology:
    The journal covers various aspects of liver diseases, including hepatitis, liver cirrhosis, hepatocellular carcinoma, and complications arising from liver disorders. It emphasizes both clinical and molecular research that enhances understanding and treatment of these conditions.
  2. Gastrointestinal Disorders:
    Research related to gastrointestinal disorders, including inflammatory bowel disease, gastrointestinal cancers, and metabolic liver diseases, is a key focus. The journal publishes studies that explore pathophysiology, diagnosis, and treatment strategies.
  3. Noninvasive Diagnostic Techniques:
    There is a consistent emphasis on noninvasive methods for diagnosing liver and gastrointestinal conditions, such as elastography and imaging techniques, reflecting a trend toward reducing invasive procedures in clinical practice.
  4. Public Health and Epidemiology:
    The journal addresses public health issues related to gastrointestinal and liver diseases, including epidemiological studies that investigate disease prevalence, risk factors, and healthcare utilization.
  5. Innovative Therapeutic Approaches:
    The publication of studies on novel therapeutic interventions, including pharmacological treatments, surgical techniques, and integrative approaches, highlights the journal's commitment to improving patient care.
  6. Biomarkers and Prognostic Models:
    There is a strong focus on identifying biomarkers and developing prognostic models that aid in predicting disease outcomes and guiding treatment decisions.
Recent publications in the Canadian Journal of Gastroenterology and Hepatology indicate a shift toward several emerging themes that are gaining traction. These themes reflect evolving priorities in research and clinical practice within the fields of gastroenterology and hepatology.
  1. Nonalcoholic Fatty Liver Disease (NAFLD) and Metabolic Disorders:
    There is a growing body of research focused on NAFLD, particularly its relationship with metabolic disorders such as obesity and diabetes. This reflects an increased awareness of the systemic implications of liver health.
  2. Telemedicine and Remote Patient Monitoring:
    With the rise of telehealth, studies exploring the feasibility and effectiveness of remote monitoring for managing gastrointestinal conditions have become more prominent, especially in the context of the COVID-19 pandemic.
  3. Immunotherapy for Liver and Gastrointestinal Cancers:
    Research on immunotherapeutic strategies for treating liver and gastrointestinal cancers is on the rise, highlighting a shift toward innovative cancer treatments.
  4. Artificial Intelligence and Machine Learning in Diagnostics:
    Emerging themes include the application of AI and machine learning in diagnostic processes, particularly in predicting outcomes and personalizing treatment plans.
  5. Public Health Implications of Gastroenterological Diseases:
    An increase in studies addressing the public health impacts of gastrointestinal diseases, including healthcare costs and access to care, underscores the importance of these issues in the broader healthcare landscape.

Declining or Waning

While the journal has a robust focus on various areas, some themes appear to be declining in prominence over recent years. This shift may reflect changing research priorities or advancements in clinical practices.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in studies focusing solely on traditional surgical approaches for gastrointestinal diseases, possibly as newer, less invasive techniques gain favor.
  2. Conventional Imaging Techniques:
    The emphasis on conventional imaging methods appears to be waning as the field increasingly embraces advanced imaging modalities and radiomics for better diagnostic accuracy.
  3. Acute Gastrointestinal Conditions:
    Research specifically targeting acute gastrointestinal conditions seems less frequent, indicating a potential shift toward chronic disease management and long-term outcomes.
  4. Basic Science Research:
    There is a declining trend in purely basic science studies, as the journal increasingly prioritizes translational and clinical research that directly impacts patient care.
  5. Single-Center Studies:
    The frequency of single-center studies has decreased, reflecting a trend toward multicenter collaborations that enhance the generalizability of findings.

Similar Journals

International Journal of Hepatology

Unveiling critical research to transform liver care.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Gastroenterologia y Hepatologia

Advancing knowledge in gastrointestinal and liver health.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.

Cellular and Molecular Gastroenterology and Hepatology

Exploring breakthroughs in cellular and molecular research.
Publisher: ELSEVIER INCISSN: 2352-345XFrequency: 12 issues/year

Cellular and Molecular Gastroenterology and Hepatology, published by Elsevier Inc, is a premier Open Access journal dedicated to advancing the understanding and treatment of gastrointestinal and liver diseases. Since its inception in 2015, this journal has established itself as a leading publication within its field, boasting impressive metrics with a 2023 Q1 ranking in both Gastroenterology and Hepatology. It ranks #10 out of 167 in Gastroenterology and #11 out of 82 in Hepatology on Scopus, placing it in the 94th and 87th percentiles, respectively. This journal aims to disseminate high-quality, peer-reviewed research that fosters innovative solutions for clinical challenges, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access, all published content is readily available to a global audience, ensuring that critical findings in cellular and molecular biology related to gastroenterology and hepatology reach those who can benefit the most from the latest advances in the field. For more information, please visit us at our address in San Diego, CA, or explore our articles online.

Hepatology Forum

Fostering collaboration in the fight against liver disorders.
Publisher: KARE PUBLISSN: 1307-5888Frequency: 4 issues/year

Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.

ACTA GASTRO-ENTEROLOGICA BELGICA

Elevating Clinical Insights for Optimal Patient Outcomes
Publisher: UNIV CATHOLIQUE LOUVAIN-UCLISSN: 1784-3227Frequency: 4 issues/year

ACTA GASTRO-ENTEROLOGICA BELGICA is a prestigious journal dedicated to advancing the field of gastroenterology through the dissemination of high-quality research and clinical insights. Published by UNIVERSITE CATHOLIQUE DE LOUVAIN (UCL), this journal is an essential resource for researchers, healthcare professionals, and students alike, focusing on a wide range of topics including gastrointestinal diseases, treatments, and innovations in clinical practices. While the journal operates under a traditional access model, its impact in the academic community is significant, ensuring that vital research is communicated effectively to stakeholders in Belgium and beyond. With its commitment to academic excellence, ACTA GASTRO-ENTEROLOGICA BELGICA plays a crucial role in fostering high-level discourse and collaboration among experts in the field, ultimately encouraging advancements that improve patient care and outcomes.

World Journal of Hepatology

Elevating the discourse on liver health and disease management.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

Translational Gastroenterology and Hepatology

Connecting Research to Real-World Solutions in Hepatology.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

JGH Open

Elevating Research, Enhancing Lives
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Elevating standards in gastrointestinal and liver disease research.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

Expert Review of Gastroenterology & Hepatology

Exploring the Frontiers of Digestive Health
Publisher: TAYLOR & FRANCIS LTDISSN: 1747-4124Frequency: 8 issues/year

Expert Review of Gastroenterology & Hepatology is a premier journal published by Taylor & Francis Ltd that aims to bridge the gap between clinical practice and research in the fields of gastroenterology and hepatology. Established in 2007, this journal has rapidly gained recognition, boasting a Q1 ranking in Gastroenterology and a Q2 ranking in Hepatology for 2023, while achieving impressive Scopus rankings of 31st and 25th respectively in these disciplines, placing it within the top 81st and 70th percentiles. The journal’s objective is to provide a comprehensive platform for the latest developments, innovative treatments, and critical reviews, catering to researchers, healthcare professionals, and students alike. Located in the United Kingdom, the journal does not operate under an open access model but ensures that its content is accessible to a global audience through institutional subscriptions. By consistently publishing high-impact reviews and articles, Expert Review of Gastroenterology & Hepatology solidifies its role as a vital resource in advancing knowledge and clinical practice within these challenging and evolving fields.